GlassScriptPhysician profile
Karly Janell Borunda
NPI 1174179725
$2,490.64
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,159 · 2022: $111 · 2023: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $499.85 | 2021-2023 | |
| Csl Behring | $277.52 | 2021-2023 | Hizentra |
| Biogen, INC. | $213.35 | 2021 | |
| Sk Life Science, INC. | $202.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $200.38 | 2021 | |
| Eisai INC. | $121.18 | 2021 | |
| Emd Serono, INC. | $101.16 | 2021 | |
| Novartis Pharmaceuticals Corporation | $95.82 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $94.08 | 2021 | |
| Adamas Pharmaceuticals, INC. | $84.06 | 2021 | |
| Lundbeck LLC | $78.76 | 2021 | |
| Amgen INC. | $74.26 | 2021 | |
| Amneal Pharmaceuticals LLC | $69.76 | 2021 | |
| Upsher-Smith Laboratories LLC | $69.19 | 2021 | |
| Lilly USA, LLC | $38.03 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $35.22 | 2021 | |
| Neurelis, INC. | $34.41 | 2021 | |
| Banner Life Sciences, LLC | $33.85 | 2021 | |
| Tanabe Pharma America, INC. | $33.62 | 2021 | |
| Genentech USA, INC. | $22.95 | 2021 | |
| Ucb, INC. | $22.63 | 2021 | |
| Neurocrine Biosciences, INC. | $22.61 | 2021 | |
| Sunovion Pharmaceuticals INC. | $19.95 | 2022 | |
| Jazz Pharmaceuticals INC. | $19.94 | 2021 | |
| Avanir Pharmaceuticals, INC. | $14.46 | 2021 | |
| Merck Sharp & Dohme LLC | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karly Borunda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.